This I believe is great news, the company is now well funded to pursue existing developments, they have expanded their license with Dolce and they have entice a specialist Fund manager -- Merchant to commit $3.56. https://www.merchantfunds.com.au/wp-content/uploads/2021/01/MFM-Newsletter-Dec-2020.pdf
They appear to be very selective on their investments and have had an impressive record since 2013-- look at above newsletter and note their comments on Medical Cannabis.
NTI have confirmed the human trials will begin this quarter.
The market has got it wrong by selling us down this morning and I'll be buying more at 6.5
Cheers
Ann: Neurotech Secures $3.56m in Funding, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
